侵袭性霉菌感染的早期诊断
综述指出侵袭性霉菌感染(IMI)是血液肿瘤及长期免疫抑制患者的主要死因,早期诊断和及时抗真菌治疗至关重要。诊断按确诊、临床诊断和疑似分级,需结合影像学、微生物学工具(镜检、培养、PCR、真菌生物标志物)和组织病理学。单一检测敏感性和特异性不足,最佳策略为多手段联合,且诊断路径应结合本地流行病学和检测可及性个体化。
要点
- IMI诊断按确诊、临床诊断、疑似三级概率分层。
- CT影像、真菌生物标志物(GM、G试验)和分子检测是核心手段。
- 单一检测敏感性和特异性不足,应联合多策略诊断。
核心结论
- 侵袭性霉菌感染早期诊断困难,需结合影像学、微生物学和组织病理学多手段联合评估。
- 单一诊断试验敏感性和特异性不足,最佳策略为多策略组合。
研究设计与样本
- 综述性文章,总结侵袭性霉菌感染的诊断策略与检测工具。
主要发现
- IMI是血液肿瘤及长期免疫抑制患者的主要死因。
- 诊断按确诊、临床诊断和疑似概率分级表达。
- 影像学(CT)、微生物学工具(镜检、培养、PCR、真菌生物标志物)和组织病理学是诊断支柱。
- 丝状真菌PCR(主要针对曲霉或毛霉目)的发展及标准化进展可能推动未来诊断进步。
关键数值与推荐
- 影像学(CT扫描)为诊断支柱之一。
- 真菌生物标志物包括半乳甘露聚糖(GM)和1,3-β-D-葡聚糖(G试验)。
- 分子工具包括丝状真菌PCR,主要针对曲霉或毛霉目。
临床怎么用
- 对高危患者应联合影像学、真菌生物标志物和分子检测进行诊断评估。
- 诊断路径应结合本中心IMI流行病学和检测可及性个体化制定。
局限性
- 目前可用的诊断试验均无法单独提供足够的敏感性和特异性。
- 真菌PCR技术标准化仍在进展中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Invasive mould infections (IMIs), such as invasive aspergillosis or mucormycosis, are a major cause of death in patients with haematological cancer and in patients receiving long-term immunosuppressive therapy. Early diagnosis and prompt initiation of antifungal therapy are crucial steps in the management of patients with IMI. The diagnosis of IMI remains a major challenge, with an increased spectrum of fungal pathogens and a diversity of clinical and radiological presentations within the expanding spectrum of immunocompromised hosts. Diagnosis is difficult to establish and is expressed on a scale of probability (proven, probable and possible). Imaging (CT scan), microbiological tools (direct examination, culture, PCR, fungal biomarkers) and histopathology are the pillars of the diagnostic work-up of IMI. None of the currently available diagnostic tests provides sufficient sensitivity and specificity alone, so the optimal approach relies on a combination of multiple diagnostic strategies, including imaging, fungal biomarkers (galactomannan and 1,3-β-d-glucan) and molecular tools. In recent years, the development of PCR for filamentous fungi (primarily Aspergillus or Mucorales) and the progress made in the standardization of fungal PCR technology, may lead to future advances in the field. The appropriate diagnostic approach for IMI should be individualized to each centre, taking into account the local epidemiology of IMI and the availability of diagnostic tests.
引用
- Lamoth F, Calandra T. Early diagnosis of invasive mould infections and disease. J Antimicrob Chemother. 2017. PMID: 28355464. doi:10.1093/jac/dkx030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。